Nov 02, 2018
CytRx Corporation Reports Third Quarter 2018 Financial Results
Oct 31, 2018
Key Emerging Oncology Trends By Big Pharma Strengthen CytRx's Rationally Designed, Targeted Therapies Pipeline
Oct 29, 2018
CytRx to Hold Third Quarter 2018 Financial Results Conference Call and Webcast on Friday, November 2, 2018
Sep 25, 2018
CytRx Corporation to Present at the 2018 MicroCap Conference
Sep 13, 2018
CytRx Corporation Announces Receipt of Milestone Payment from Orphazyme A/S
Aug 27, 2018
CytRx Corporation to Present at the H.C. Wainwright & Co. 20th Annual Global Investment Conference in New York City September 4-6, 2018
Aug 06, 2018
CytRx Corporation Reports Second Quarter 2018 Financial Results
Aug 01, 2018
CytRx Corporation Pays Off Balance of Outstanding Debt
Jul 30, 2018
CytRx Corporation to Hold Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018
Jul 25, 2018
CytRx Announces Centurion BioPharma Corporation's Filing of a Provisional Patent Application
Jul 23, 2018
CytRx Corporation Announces Expiration of Outstanding Warrants
Jul 16, 2018
CytRx Corporation to Present at the Singular Research Summer Solstice 2018 Conference
Jun 28, 2018
CytRx Corporation Highlights Aldoxorubicin Included in New NantCell Inc. Triple Negative Breast Cancer Clinical Trial
Jun 25, 2018
CytRx Corporation Joins Russell Microcap® Index
Jun 21, 2018
CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology
Jun 07, 2018
CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data Presented at the American Society of Clinical Oncology 2018 Annual Meeting
May 30, 2018
CytRx Corporation to Present at 8th Annual LD Micro Invitational Conference
May 17, 2018
CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data to be Presented at the American Society of Clinical Oncology 2018 Annual Meeting
May 15, 2018
CytRx Announces Closing of $7.0 Million Registered Direct Offering
May 08, 2018
CytRx Reports First Quarter 2018 Financial Results